# ClinicalTrials.gov record NCT00427349

> PeptideScanner retained ClinicalTrials.gov record NCT00427349 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-05, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct00427349-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-07-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00427349-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00427349-octreotide-v1.json
- Content SHA-256: `db0492ac7777dcc34b5dbf58e4ae84e866f4ec9dc2487909e6279ad77efd8ff4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00427349 ([`ctg-observation-nct00427349-2023-07-05-226b17a41d37`](#source-ctg-observation-nct00427349-2023-07-05-226b17a41d37))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00427349 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-05, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00427349-2023-07-05-226b17a41d37`](#source-ctg-observation-nct00427349-2023-07-05-226b17a41d37))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00427349 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-05, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00427349-2023-07-05-226b17a41d37`](#source-ctg-observation-nct00427349-2023-07-05-226b17a41d37))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00427349-2023-07-05-226b17a41d37`](#source-ctg-observation-nct00427349-2023-07-05-226b17a41d37))

## Sources

<a id="source-ctg-observation-nct00427349-2023-07-05-226b17a41d37"></a>
- **ClinicalTrials.gov record NCT00427349 · retained source version 2023-07-05:226b17a41d3718e8a7bfe902342164445ab4e9f6ef4a09ccdf44b8d2a224a1f3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00427349) (`ctg-observation-nct00427349-2023-07-05-226b17a41d37`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00427349." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00427349-octreotide-v1.json SHA-256: db0492ac7777dcc34b5dbf58e4ae84e866f4ec9dc2487909e6279ad77efd8ff4.